FacultyFaculty/Author Profile
Brandon A. Van Dyke

Brandon A. Van Dyke

Skadden Arps Slate Meagher & Flom LLP

New York, NY, USA


Brandon Van Dyke focuses his practice on mergers and acquisitions and corporate and securities law matters.

Mr. Van Dyke has represented acquirors, targets and financial advisors in a number of significant U.S. and cross-border mergers, acquisitions, takeovers (both negotiated and contested), leveraged buyouts and other corporate matters. In addition, he has provided transactional advice to companies implementing corporate restructuring plans.

Industries in which Mr. Van Dyke has had substantial transactional involvement include media and entertainment, mining and metals, chemicals, pharmaceutical and health care.

In 2012, The M&A Advisor selected Mr. Van Dyke as one of the top 40 M&A professionals under the age of 40.

Representations and transactions include:
  • DuPont in its $4.9 billion sale of DuPont Performance Coatings to The Carlyle Group;
  • News Corporation in its announced pursuit of the separation of its publishing and media and entertainment businesses;
  • Gilead Sciences, Inc. in its $11 billion acquisition of Pharmasset, Inc., a transaction that was recognized in the 2012 Financial Times “US Innovative Lawyers” report;
  • DuPont in its $6.6 billion acquisition of Danisco A/S by tender offer, one of the largest transactions in the history of Denmark up to that time;
  • Endo Pharmaceuticals in its $2.9 billion acquisition of American Medical Systems;
  • Endo Pharmaceuticals Holdings in its $1.2 billion acquisition of Qualitest (a portfolio company of Apax Partners) and in its approximately $250 million acquisition of HealthTronics, Inc. by tender offer;
  • Medtronic, Inc. in its $487 million sale of its Physio-Control division to affiliates of Bain Capital, LLC;
  • Dow Jones & Company in its $675 million financial index joint venture with CME Group;
  • CIT Group in a cash debt tender offer in connection with its restructuring plan;
  • Express Scripts in its $4.675 billion acquisition of WellPoint Inc.’s NextRx subsidiaries;
  • News Corporation in partnership with Permira Advisers Ltd., a private equity firm in the United Kingdom, in their $3.7 billion going-private acquisition of NDS Group plc;
  • Safeco in its $6.2 billion merger with Liberty Mutual Insurance Company;
  • News Corporation in its $5.6 billion acquisition of Dow Jones & Company;
  • Alcoa Inc. in its commenced but terminated $27 billion hostile exchange offer for Alcan Inc.;
  • News Corporation in its $11 billion buyback of its stock from Liberty Media in exchange for cash and assets;
  • Serono S.A. and the Bertarelli Family in the approximately €10.6 billion acquisition of Serono by Merck KGaA;
  • News Corporation in taking Fox Entertainment Group private for $6 billion in News Corporation stock;
  • Marathon Fund in its proposed but terminated approximately $1 billion acquisition of Shopko Stores, Inc.;
  • DST Systems in its acquisition of the Health Plans Solutions unit from Computer Sciences Corporation and its sale of its Innovis unit to Amdocs Ltd.;
  • AMC Entertainment, Inc. in its $2 billion sale to J.P. Morgan Partners and Apollo Partners Limited;
  • UnitedHealth Group Incorporated in its approximately $4.7 billion acquisition of Oxford Health Plans, Inc.; and
  • AdvancePCS in its approximately $6 billion merger with CaremarkRx, Inc.
Mr. Van Dyke also has advised several of Skadden’s investment banking clients as financial advisors in various public merger and acquisition transactions, including Goldman Sachs, Banc of America/Merrill Lynch and JPMorgan Chase as financial advisors to Pfizer in its $68 billion merger with Wyeth.

In addition, Mr. Van Dyke has advised clients with respect to responding to unsolicited acquisition proposals and other corporate preparedness matters, SEC reporting obligations, board governance, and other corporate and securities law matters.
Share
Email

  • FOLLOW PLI:
  • twitter
  • LinkedIn
  • GooglePlus
  • RSS

All Contents Copyright © 1996-2017 Practising Law Institute. Continuing Legal Education since 1933.

© 2017 PLI PRACTISING LAW INSTITUTE. All rights reserved. The PLI logo is a service mark of PLI.